Which has the lower trailing P/E, BSX or ELV?

BSX has the lower trailing P/E: BSX trades at 17.86 and ELV at 18.57. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BSX or ELV?

Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus ELV at 9.25%.

Does BSX or ELV pay a bigger dividend?

ELV pays a dividend (1.64% yield), while BSX has no payments in the available dividend history.

Is BSX or ELV more profitable?

BSX runs the higher net margin — BSX at 17.47% versus ELV at 2.47%.

How have BSX and ELV total returns compared?

Over the past 10 years, BSX delivered 6.22% and ELV delivered 14.24% annualized total return. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs Elevance Health Inc. (ELV)

A side-by-side comparison of Boston Scientific Corporation and Elevance Health Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

BSX

Boston Scientific Corporation

$65.32B

$43.95HealthcareDelayed quote: Sep 15, 2026, 10:40 AM EDT

ELV

Elevance Health Inc.

$90.62B

$417.87HealthcareDelayed quote: Sep 15, 2026, 10:35 AM EDT

Total return — BSX vs ELV

growth of $100 · dividends reinvested · last 10y

BSX +76.1% (+5.8%/yr)ELV +286.4% (+14.5%/yr)ELV compounded faster over this window

BSX ELV

BSX vs ELV: by the numbers

•ELV is the larger company ($90.62B vs $65.32B market cap).
•BSX trades at the lower trailing earnings multiple (17.86 vs 18.57 P/E), one valuation lens rather than an overall verdict.
•BSX converts more revenue to profit (17.47% vs 2.47% net margin).
•BSX grew revenue faster over the past five years (13.40% vs 9.25% CAGR).
•ELV pays a dividend (1.64% yield), while BSX has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BSX	ELV
P/E ratio	17.86	18.57
Forward P/E	13.36	15.39
P/S ratio	3.11	0.45
P/B ratio	2.62	2.02
EV / EBITDA	13.35	13.80
FCF yield	5.55%	6.94%

Profitability

Metric	BSX	ELV
Gross margin	71.16%	25.56%
Operating margin	21.46%	3.51%
Net margin	17.47%	2.47%
ROE	14.71%	11.06%
ROIC	10.57%	6.34%

Dividends

Metric	BSX	ELV
Dividend yield	N/A	1.64%
Payout ratio	N/A	30.49%

Growth (annualized)

Metric	BSX	ELV
Revenue CAGR (5Y)	13.40%	9.25%
EPS CAGR (5Y)	N/A	6.67%
FCF CAGR (5Y)	15.64%	-19.97%
Total return CAGR (5Y)	-0.67%	4.73%

Frequently asked

Which has the lower trailing P/E, BSX or ELV?: BSX has the lower trailing P/E: BSX trades at 17.86 and ELV at 18.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BSX or ELV?: Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus ELV at 9.25%.
Does BSX or ELV pay a bigger dividend?: ELV pays a dividend (1.64% yield), while BSX has no payments in the available dividend history.
Is BSX or ELV more profitable?: BSX runs the higher net margin — BSX at 17.47% versus ELV at 2.47%.
How have BSX and ELV total returns compared?: Over the past 10 years, BSX delivered 6.22% and ELV delivered 14.24% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full ELV analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio Elevance Health P/E ratio Elevance Health dividend yield Boston Scientific ROE Elevance Health ROE Boston Scientific operating margin Elevance Health operating margin Boston Scientific revenue growth Elevance Health revenue growth Boston Scientific free cash flow Elevance Health free cash flow

Boston Scientific & Elevance Health appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.